Intuitive Surgical, Inc.
ISRGNASDAQ
$449.81
Last price · USD
- Market cap
- $163.1B
- P/E
- 57.2x
- EV / EBITDA
- 40.1x
- P/S
- 16.2x
- FCF yield
- 1.5%
- Div. yield
- 0.00%
Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.
Revenue
$10.06B
+20.5%
4Y CAGR +15.2%
Gross profit
$6.64B
+17.9%
4Y CAGR +13.8%
Operating income
$2.95B
+25.4%
4Y CAGR +12.8%
Net income
$2.86B
+23.0%
4Y CAGR +13.8%
EPS (diluted)
$7.87
+22.6%
4Y CAGR +14.0%
Free cash flow
$2.49B
+91.0%
4Y CAGR +9.4%
Revenue & net income
Fiscal 2021–2025 · USD
RevenueNet income
Valuation
At $449.81 · FY2025 fundamentals
- Market cap
- $163.1B
- Enterprise value
- $160.1B
- P/E
- 57.2x
- P/S
- 16.2x
- P/B
- 9.2x
- EV / EBITDA
- 40.1x
- EV / Sales
- 15.9x
- Earnings yield
- 1.8%
- FCF yield
- 1.5%
- Shareholder yield
- 1.4%
Profitability
Margins as a share of revenue
| Metric | Latest | 4Y ago | Trend |
|---|---|---|---|
| Gross margin | 66.0%-3.3pp | 69.3% | |
| Operating margin | 29.3%-2.6pp | 31.9% | |
| EBITDA margin | 39.6%+1.1pp | 38.5% | |
| Net margin | 28.4%-1.5pp | 29.9% | |
| FCF margin | 24.7%-5.7pp | 30.4% |
Returns & financial health
FY2025 with 4-year trend
| Metric | Latest | 4Y ago | Trend |
|---|---|---|---|
| Return on equity | 16.0% | 14.3% | |
| Return on invested capital | 17.3% | 15.5% | |
| Return on assets | 13.8% | 12.6% | |
| Debt / equity | 0.02x | 0.01x | |
| Net debt / EBITDA | -0.77x | -0.55x | |
| Current ratio | 4.87x | 5.08x |
Cash & equivalents
$3.37B
Total debt
$303M
Capital allocation
How ISRG used its cash in FY2025
- Operating cash flow
- $3.03B
- Capital expenditure
- $540M
- Dividends paid
- $0.00
- Share repurchases
- $2.30B
- Stock-based compensation
- $788M
- Diluted shares
- 362.7M
- Share count change (4Y)
- -0.8%
Analyst estimates
Consensus for upcoming fiscal years
| Fiscal year | Revenue | Growth | EPS | Growth |
|---|---|---|---|---|
| FY2025 actual | $10.06B | $7.87 | ||
| FY2026E16 analysts | $11.89B | +18.2% | $11.20 | +42.3% |
| FY2027E17 analysts | $13.33B | +12.1% | $12.39 | +10.6% |
| FY2028E10 analysts | $14.99B | +12.4% | $13.93 | +12.5% |
About Intuitive Surgical, Inc.
Healthcare · Medical - Instruments & Supplies
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets.
intuitive.com- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- David J. Rosa
- Employees
- 17,021
- Headquarters
- Sunnyvale, CA, US
- IPO date
- 2000-06-16
Intuitive Surgical, Inc. (ISRG) — frequently asked questions
Answered from the company's SEC filings
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools.
Explore the full income statement, balance sheet and cash flow statement. Not investment advice.